Abstract

Proangiotensin-12 [Ang-(1-12)] is a C-terminal extended form of Ang I [Ang I-Leu-Tyr] originally isolated from the rat small intestine. Additional studies showed that while both ACE and chymase cleaved Ang II from Ang-(1-12) in the rat heart, chymase but not ACE metabolized Ang-(1-12) in the human heart. This study characterized the expression of Ang-(1-12)/chymase in human atrial tissue to gain an insight into the potential role of this Ang II-forming substrate in cardiac disease. Left (LA; n=16) and right (RA; n=14) portions of atrial appendages were obtained from humans undergoing heart surgery. Quantitative Ang-(1-12) immunohistochemistry (Image J software) was performed using a high affinity purified antibody directed to the COOH-terminus of the full length of human Ang-(1-12) in all samples (LA: male=13 and female=3; RA: male=9 and female=5). Chymase activity was determined by HPLC in plasma membranes from left (males=7 and females=3) and right atria (males=7 and females=3). Quantitative analysis of Ang-(1-12) expression revealed significantly higher Ang-(1-12) expression in LA (Intensity: 35.37±6.24 units) versus RA (19.38±2.38 units, p=0.03) appendages. Likewise, chymase activity was higher in the LA (52.02±5.20 fmol/mg/min) compared to RA (18.09±3.05, p<0.0001) tissues. Expression of Ang-(1-12) in atria did not correlate with subject’s age, disease process or medications. The novel demonstration of higher Ang-(1-12) expression and chymase activity in human LA reveals a critical role of this tissue Ang II forming axis in modulating the diastolic and systolic properties of this cardiac cavity.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call